{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-020163","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2023-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.756328+00:00","generated_at":"2026-06-13T07:23:19.505728+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GeoVax Labs enters ATM equity offering agreement for up to $6.529M","bullets":["Company may sell up to $6,529,000 of common stock at market prices via H.C. Wainwright as sales agent.","Wainwright receives 3% commission on gross proceeds; company also reimburses up to $50,000 in expenses.","Sales will be made under existing effective S-3 shelf registration (File No. 333-252437).","Agreement dated July 18, 2023; no obligation to sell any shares.","Proceeds used for general corporate purposes; potential dilution for existing shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-020163","json":"https://secwatch.observer/filing/0001437749-23-020163.json","markdown":"https://secwatch.observer/filing/0001437749-23-020163.md","text":"https://secwatch.observer/filing/0001437749-23-020163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774923020163/0001437749-23-020163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774923020163/govx20230718_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T07:23:19.505728+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16f579ae0205ebd30de409457b628ddaa5fa338c","claim":"GeoVax Labs, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $6,529,000 (effective 2023-07-18).","evidence_excerpt":"On July 18, 2023, GeoVax Labs, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent, pursuant to which we may offer and sell, from time to time, through Wainwright shares of our common stock, $0.001 par value per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923020163/0001437749-23-020163-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"up to $6,529,000"},{"label":"Effective","value":"2023-07-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}